Get started
Author

Nalinee Sangrujee

Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models
2013 · Jeffrey W Eaton, Nicolas A Menzies, et al. · The Lancet Global Health · 240
PDF
HIV Treatment as Prevention: Issues in Economic Evaluation
2012 · Till Bärnighausen, Joshua A. Salomon, et al. · PLoS Medicine · 62
PDF
PEPFAR’S Past And Future Efforts To Cut Costs, Improve Efficiency, And Increase The Impact Of Global HIV Programs
2012 · Charles B. Holmes, John M. Blandford, et al. · Health Affairs · 53
Cost-Effectiveness Analysis of Diagnostic Options for Pneumocystis Pneumonia (PCP)
2011 · Julie R. Harris, Barbara J. Marston, et al. · PLoS ONE · 52
PDF
Global Surveillance and the Value of Information: The Case of the Global Polio Laboratory Network
2006 · Esther De Gourville, Radboud J. Duintjer Tebbens, et al. · Risk Analysis · 50
Cost-effectiveness of three different vaccination strategies against measles in Zambian children
2003 · Gustavo H Dayan, Lisa Cairns, et al. · Vaccine · 49
Cost-Effectiveness of Tuberculosis Diagnostic Strategies to Reduce Early Mortality Among Persons With Advanced HIV Infection Initiating Antiretroviral Therapy
2012 · Taiwo O. Abimbola, Barbara J. Marston, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 45
Measles supplemental immunization activities improve measles vaccine coverage and equity: Evidence from Kenya, 2002
2006 · Maya Vijayaraghavan, Rebecca M. Martin, et al. · Health Policy · 43
Factors Affecting U.S. Manufacturers’ Decisions To Produce Vaccines
2005 · Margaret S. Coleman, Nalinee Sangrujee, et al. · Health Affairs · 41
Cost analysis of post-polio certification immunization policies.
2004 · Nalinee Sangrujee, Victor M Cáceres, et al. · Europe PMC (PubMed Central) · 40
The Costs of Future Polio Risk Management Policies
2006 · Radboud J. Duintjer Tebbens, Nalinee Sangrujee, et al. · Risk Analysis · 36
Policy decision options during the first 5 years following certification of polio eradication.
2003 · Nalinee Sangrujee, Radboud J Duintjer Tebbens, et al. · PubMed · 33
The incremental cost of switching from Option B to Option B+ for the prevention of mother-to-child transmission of HIV
2014 · Lisa O’Brien, Nathan Shaffer, et al. · Bulletin of the World Health Organization · 29
PDF
Development and Consideration of Global Policies for Managing the Future Risks of Poliovirus Outbreaks: Insights and Lessons Learned Through Modeling
2006 · Kimberly M. Thompson, Radboud J. Duintjer Tebbens, et al. · Risk Analysis · 21
Cost-effectiveness of the Three I's for HIV/TB and ART to prevent TB among people living with HIV
2014 · S. Gupta, T. Abimbola, et al. · The International Journal of Tuberculosis and Lung Disease · 15
Implementation and Operational Research
2015 · Tyler Smith, Taraz Samandari, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 8
Translating Technical Support Into Country Action: The Role of the Interagency Task Team on the Prevention and Treatment of HIV Infection in Pregnant Women, Mothers, and Children in the Global Plan Era
2017 · Chewe Luo, Gottfried Hirnschall, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 4
Cost-Effectiveness Of Alternative Policies To Reduce TB Disease And Death In HIV-Infected Persons In Botswana
2011 · Tyler Smith, Taraz Samandari, et al. · American Journal of Respiratory and Critical Care Medicine · 2
In sickness or in health : risk of infant mortality and the demand for immunizations
2002 · Nalinee Sangrujee · University Microfilms International eBooks
Works count: 20
Citation count: 823
H-index: 15
I10-index: 15
Year
Topic
Type